Scientists develop method to examine HIV drugs' structure

01/31/2010 | Reuters

A team of U.S. and British researchers created a crystal to further examine the 3-D structure of HIV drugs from Merck & Co. and Gilead Sciences and how they bind to and inhibit the integrase enzyme. The crystal, which was grown from an integrase found in a retrovirus similar to HIV, could help improve HIV medicines and prevent drug resistance, according to the study.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President - Government Products
Health Alliance Plan
Detroit, MI
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC